| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Aysun Kalenderoglu, Mehmet Hamdi Orum, Ayse Sevgi Karadag, Ali Kustepe, Mustafa Celik, Oguzhan Bekir Egilmez, Dilay Eken-Gedi. Increases in retinal nerve fiber layer thickness may represent the neuroprotective effect of cannabis: an optical coherence tomography study. Journal of addictive diseases. vol 38. issue 3. 2021-09-02. PMID:32525766. |
the aim of this study was to evaluate ganglion cell layer (gcl), inner plexiform layer (ipl), retinal nerve fiber layer (rnfl), and choroidal layer thickness in patients diagnosed with sud especially cannabis use disorder (cud). |
2021-09-02 |
2023-08-13 |
Not clear |
| Lourah M Kelly, Tess K Drazdowski, Nicholas R Livingston, Kristyn Zaja. Demographic risk factors for co-occurring suicidality and cannabis use disorders: Findings from a nationally representative United States sample. Addictive behaviors. vol 122. 2021-09-02. PMID:34284313. |
burgeoning research suggests a link between suicidality (i.e., ideation, attempts) and cannabis use; however, little is known about which demographic groups are at increased risk of co-occurring suicidality and cannabis use disorders (cud). |
2021-09-02 |
2023-08-13 |
Not clear |
| Joshua A Lile, Joseph L Alcorn, Lon R Hays, Thomas H Kelly, William W Stoops, Michael J Wesley, Philip M Westgat. Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users. Experimental and clinical psychopharmacology. 2021-08-21. PMID:33983765. |
no medications are approved for cannabis use disorder (cud), though a small clinical trial demonstrated that the voltage-dependent calcium channel (vdcc) ligand gabapentin reduced cannabis use in treatment seekers. |
2021-08-21 |
2023-08-13 |
human |
| Alain Lekoubou, Jonah Fox, Kinfe G Bishu, Bruce Ovbiagel. Trends in documented cannabis use disorder among hospitalized adult epilepsy patients in the United States. Epilepsy research. vol 163. 2021-08-18. PMID:32361206. |
given ongoing contemporary societal controversies about medicinal and recreational cannabis use, we aimed to ascertain recent nationwide prevalence, trends, and psychiatric diagnoses associated with cannabis use disorders (cud) among epilepsy patients. |
2021-08-18 |
2023-08-13 |
Not clear |
| Ileana Pacheco-Colón, Catalina Lopez-Quintero, Stefany Coxe, Jorge M Limia, William Pulido, Karen Granja, Dayana C Paula, Ingrid Gonzalez, J Megan Ross, Jacqueline C Duperrouzel, Samuel W Hawes, Raul Gonzale. Risky decision-making as an antecedent or consequence of adolescent cannabis use: findings from a 2-year longitudinal study. Addiction (Abingdon, England). 2021-08-17. PMID:34184776. |
we also measured the role of dm as a risk factor for cannabis use disorder (cud) onset. |
2021-08-17 |
2023-08-13 |
Not clear |
| Janna Cousijn, Yara J Toenders, Laura S van Velzen, Anne Marije Kaa. The relation between cannabis use, dependence severity and white matter microstructure: A diffusion tensor imaging study. Addiction biology. 2021-08-17. PMID:34402136. |
despite the significant societal and personal burden of cannabis use, the impact of long-term use and cannabis use disorder (cud) on white matter microstructure is still unclear. |
2021-08-17 |
2023-08-13 |
Not clear |
| Caroline A Arout, Ziva D Cooper, Stephanie Collins Reed, Richard W Foltin, Sandra D Comer, Frances R Levin, Margaret Hane. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. Addiction biology. vol 26. issue 4. 2021-08-16. PMID:33389797. |
there are no fda-approved treatments for cannabis use disorder (cud). |
2021-08-16 |
2023-08-13 |
human |
| Caroline A Arout, Ziva D Cooper, Stephanie Collins Reed, Richard W Foltin, Sandra D Comer, Frances R Levin, Margaret Hane. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. Addiction biology. vol 26. issue 4. 2021-08-16. PMID:33389797. |
fifteen normal-weight, daily cannabis users (4f, 11m) not seeking treatment for cud completed the study. |
2021-08-16 |
2023-08-13 |
human |
| Caroline A Arout, Ziva D Cooper, Stephanie Collins Reed, Richard W Foltin, Sandra D Comer, Frances R Levin, Margaret Hane. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. Addiction biology. vol 26. issue 4. 2021-08-16. PMID:33389797. |
overall, lorcaserin's ability to decrease drug taking and cannabis craving in nontreatment-seeking cannabis users supports further investigation of 5ht-2c agonists as potential pharmacotherapies for cud. |
2021-08-16 |
2023-08-13 |
human |
| James J Prisciandaro, William Mellick, Lindsay M Squeglia, Sara Hix, Lauren Arnold, Bryan K Tollive. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders. Addiction biology. 2021-08-14. PMID:34390300. |
disrupted brain gamma-aminobutyric acid (gaba)/glutamate homeostasis is a promising target for pharmacological intervention in co-occurring bipolar disorder (bd) and cannabis use disorder (cud). |
2021-08-14 |
2023-08-13 |
human |
| Maximilian Meyer, Marc Walter, Stefan Borgwardt, Alexandra Scheidegger, Elisabeth Lang, Patrick Köc. Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder. Frontiers in psychiatry. vol 12. 2021-08-10. PMID:34366942. |
to date, no pharmacotherapy is available for patients with cannabis use disorder (cud). |
2021-08-10 |
2023-08-13 |
Not clear |
| Nicholas A Livingston, Stacey L Farmer, Colin T Mahoney, Brian P Marx, Terence M Kean. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2021-08-05. PMID:34351175. |
cannabis use disorder (cud) is the most common non-alcohol related substance use disorder (sud) in the united states and is especially prevalent among returning veterans. |
2021-08-05 |
2023-08-13 |
Not clear |
| Nicholas A Livingston, Stacey L Farmer, Colin T Mahoney, Brian P Marx, Terence M Kean. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder. Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2021-08-05. PMID:34351175. |
the long-term mental health correlates of cud remain unknown, which is significant given the rise in legalization and also recreational and medicinal cannabis use nationally. |
2021-08-05 |
2023-08-13 |
Not clear |
| Matthew C Enkema, Deborah S Hasin, Kendall C Browne, Malki Stohl, Dvora Shmulewitz, David S Fink, Mark Olfson, Silvia S Martins, Kipling M Bohnert, Scott E Sherman, Magdalena Cerda, Melanie Wall, Efrat Aharonovich, Salomeh Keyhani, Andrew J Saxo. Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Pain. 2021-07-29. PMID:34108436. |
differences in prevalence of nonmedical cannabis use and cannabis use disorder (cud) were examined across 2 groups: veterans or nonveterans and those reporting or not reporting recent pain. |
2021-07-29 |
2023-08-13 |
Not clear |
| Matthew C Enkema, Deborah S Hasin, Kendall C Browne, Malki Stohl, Dvora Shmulewitz, David S Fink, Mark Olfson, Silvia S Martins, Kipling M Bohnert, Scott E Sherman, Magdalena Cerda, Melanie Wall, Efrat Aharonovich, Salomeh Keyhani, Andrew J Saxo. Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Pain. 2021-07-29. PMID:34108436. |
prevalence differences (pds) for 3 cannabis outcomes (1) past-year nonmedical cannabis use, (2) frequent (≥3 times a week) nonmedical use, and (3) dsm-5 cud were estimated for those reporting recent moderate to severe pain (veterans or nonveterans) and veterans reporting or not reporting recent pain. |
2021-07-29 |
2023-08-13 |
Not clear |
| Matthew C Enkema, Deborah S Hasin, Kendall C Browne, Malki Stohl, Dvora Shmulewitz, David S Fink, Mark Olfson, Silvia S Martins, Kipling M Bohnert, Scott E Sherman, Magdalena Cerda, Melanie Wall, Efrat Aharonovich, Salomeh Keyhani, Andrew J Saxo. Pain, cannabis use, and physical and mental health indicators among veterans and nonveterans: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Pain. 2021-07-29. PMID:34108436. |
among veterans, the prevalence of frequent cannabis use was greater among those with pain (pd = 1.92%, 98% ci [0.21-3.63]), and among veterans residing in a state with mcls, the prevalence of cud was greater among those reporting recent pain (pd = 3.88%, 98% ci [0.36-7.39]). |
2021-07-29 |
2023-08-13 |
Not clear |
| Anne Line Bretteville-Jensen, Jenny Williams, Linn Gjersin. How may alternative drug policy settings influence criminal charges? A longitudinal study of cannabis patients and a general population sample. The International journal on drug policy. vol 84. 2021-07-28. PMID:32799063. |
this study examines criminal charges amongst cannabis use disorder (cud) patients and a matched sample in a setting of drug criminalization, and simulates the effect of policy changes on the proportion obtaining a criminal record and on the number of charges for those being charged. |
2021-07-28 |
2023-08-13 |
Not clear |
| Albert J Arias, Christopher J Hammond, Joseph A Burleson, Yifrah Kaminer, Richard Feinn, John F Curry, Michael L Denni. Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder. Journal of substance abuse treatment. vol 117. 2021-07-28. PMID:32811625. |
cannabis use disorder (cud) and depression frequently co-occur in youth. |
2021-07-28 |
2023-08-13 |
Not clear |
| Albert J Arias, Christopher J Hammond, Joseph A Burleson, Yifrah Kaminer, Richard Feinn, John F Curry, Michael L Denni. Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder. Journal of substance abuse treatment. vol 117. 2021-07-28. PMID:32811625. |
in the current study, we examine the temporal relationships between cannabis use and depression in adolescents receiving evidence-based treatments for cud as part of a multisite clinical trial. |
2021-07-28 |
2023-08-13 |
Not clear |
| Robert S Stephens, Robrina Walker, Josephine DeMarce, Brian E Lozano, Jared Rowland, Denise Walker, Roger A Roffma. Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up. Journal of substance abuse treatment. vol 117. 2021-07-28. PMID:32811637. |
research has demonstrated that motivational enhancement (met) and cognitive behavioral therapy (cbt) are some of the most effective interventions for adults with cannabis use disorder (cud). |
2021-07-28 |
2023-08-13 |
human |